Current teaching states that when sodium intake is increased from low to high levels, total-body sodium (TBNa) and water increase until daily sodium excretion again equals intake. When sodium intake is reduced, sodium excretion briefly exceeds intake until the excess TBNa and water are eliminated, at which point sodium excretion again equals intake. However, careful balance studies oftentimes conflict with this view and long-term studies suggest that TBNa fluctuates independent of intake or body weight. We recently performed the opposite experiment in that we fixed sodium intake for several weeks at three levels of sodium intake and collected all urine made. We found weekly (circaseptan) patterns in sodium excretion that were inversely related to aldosterone and directly to cortisol. TBNa was not dependent on sodium intake but instead exhibited far longer (Xmonthly) infradian rhythms independent of extracellular water, body weight, or blood pressure. The findings are consistent with our ideas on tissue sodium storage and its regulation that we developed on the basis of animal research. We are implementing 23 Na-magnetic resonance imaging (MRI) to pursue open questions on sodium balance in patients. Our findings could be relevant to therapeutic strategies for hypertension and target-organ damage.
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SODIUM STORAGE
Clinicians' thinking on sodium balance is largely based on textbook teachings, paraphrased as follows ( Figure 1 ): 'If dietary intake is abruptly increased from a low-sodium diet, only about one-half is excreted on the first day. The remainder is retained augmenting sodium stores. This state of affairs elevates the plasma osmolality, stimulating both thirst and secretion of antidiuretic hormone. The increments in water intake and renal water reabsorption produce water retention, resulting in increases in effective circulating volume and weight. After 3-4 days, a new steady state is achieved in which renal sodium excretion matches intake. The same sequence occurs in reverse if sodium intake is reduced'. 1 Studies addressing this issue have generally consisted of short-term observations where extremes in salt intake were raised or lowered abruptly and sodium balance was assumed when urinary output again approached input. 2, 3 However, not all investigators have corroborated this interpretation. Heer et al. 4 performed a detailed balance study in which normal men were given sodium intakes ranging from 50 to 550 mmol per day. The food was chemically analyzed by atomic absorption spectrometry. Losses through sweat and stool were also investigated. The 24 h urinary sodium excretion (UNaV) was determined daily. Volume compartments were measured by inulin space; plasma volume was determined by 51 Cr erythrocyte labeling and hematocrit. Heer et al. found that plasma volume dose dependently increased with increasing salt intake and was increased by about 300 ml with the 550 mmol per day sodium intake. However, total-body water did not increase and there was no change in body weight, even though total body sodium content was increased by 1700 mmol. The authors concluded from the results of their two independently conducted studies that in contrast to present opinion, high sodium intake did not induce total-body water storage but instead induced a relative fluid shift from the interstitial into the intravascular space. These data were not quite in line with textbook teaching. 1 We had an opportunity to study the issue in an earlier long-term space-flight stimulation that allowed 135 days of observation. 5 Sodium intake was not fixed, but could be monitored very carefully following sodium intake of processed foods that were standardized by ashing and absorption spectrometry. We found that during the study period, subjects accumulated between 2973 and 7324 mmol of sodium and gained between 5.1 and 9.3 kg in weight. In all subjects, there was a positive correlation between changes in total-body sodium content (DTBNa) and body weight, reflecting sodium-associated volume expansion. However, toward the end of isolation, sodium gain exceeded weight gain, suggesting that sodium accumulated in an osmotically inactive form. As a matter of fact, two of three subjects showed inverse correlations between DTBNa and body weight. These findings were also out of bounds, in terms of textbook explanations. 1 We obtained insights from animal studies performed over the past decade that offered a partial explanation. We adopted techniques used by the food industry, namely the ashing of samples in a precision oven and the subsequent measurements of cations with atomic absorption spectrometry. Samples were weighed before and after ashing to estimate their water content. We found that sodium is stored without commensurate water retention in skin, 6 and presumably bound to proteoglycans. 7, 8 We learned later that a Russian physiologist had described sodium-proteoglycan binding before we came upon the idea. 9 As a matter of fact, high-salt intake resulted in increased glycosaminoglycan production and sulfatation in the skin, which was associated with Na þ storage. In reverse, a low-salt diet resulted in reduced glycosaminoglycan polymerization and sulfatation, and release of Na þ from the skin reservoir. This finding has raised the hypothesis that storage and release of Na þ from extracellular matrix components in the skin interstitium might be regulated by the negative charge density at the matrix level. This charge might act like a negatively charged capacitor, which regulates storage and release of positively charged cations by varying its negative charge.
This hypothesis was addressed earlier in studies of cartilage Na þ metabolism and the Na þ accumulation without commensurate water retention was termed 'osmotically inactive Na þ storage' . 10, 11 More recent evidence suggests that the interaction of negatively charged interstitial matrix with cellular transport mechanisms creates a highly hypertonic environment by which cartilage actively regulates its hydration state. 12, 13 Dietary salt alone did not change muscle Na þ content in the rat; however, experimental activation of the mineralocorticoid receptor led to unexpectedly high Na þ accumulation in muscle. [14] [15] [16] Energy-dispersive X-ray spectroscopic electron beam analysis revealed that this Na þ accumulation was intracellular and paralleled by commensurate intracellular K þ loss. 15 The findings suggested an osmotically neutral Na þ /K þ exchange, which did not lead to changes in the total sum of Na þ and K þ ions and thereby may not significantly alter intracellular osmotic forces.
We have since discerned regulatory aspects of extracellular osmotically inactive Na þ storage/hypertonic Na þ storage. The skin interstitium harbors glycosaminoglycans, and in this special extracellular environment, sodium concentrations and osmolality are higher than in the plasma. [6] [7] [8] [16] [17] [18] Monocyte phagocytic system cells that are outfitted with the tonicity enhancer binding protein (TonEBP/Nfat5) transcription factor sense local hypertonicity. TonEBP binds to promoters of many genes and induces their expression, thereby inducing cellular and extracellular protection against osmotic stress. Originally studied primarily in tubular cells of the renal medulla where osmotic stress is obvious, 19, 20 we found that much smaller changes in extracellular Na þ concentration around 190 mmol/l led to the activation of TonEBP expression in macrophages in vitro and in vivo. 21, 22 TonEBP then binds to the promoter region of the vascular endothelial growth factor-C (VEGF-C) gene, resulting in increased VEGF-C secretion by macrophages into the interstitium. This macrophage-derived VEGF-C leads to and induces hyperplasia of the cutaneous lymph capillary system, resulting in increased lymph-capillary density. This increased lymph-capillary density facilitates Na þ or Cl À clearance from the skin. We interfered with this process in several ways, including eliminating monocyte phagocytic system cells with clodronate 21,22 systemic 21 or local 18 overexpression of the soluble receptor for VEGF-C (VEGFR3) receptor, which acts as a VEGF-C trap, blocking VEGFR3/ VEGF-C interaction in lymph capillaries by a VEGFR3-specific antibody, 18 and most recently by conditional knockout of TonEBP in monocyte phagocytic system cells. 18 All approaches augmented skin Na þ or Cl À retention and increased blood pressure. In other words, without increased lymph-capillary density, Na þ or Cl À were less efficiently cleared from the skin. We also tested whether or not isotonic saline and deoxycorticosterone acetate-salt treatment leads to a similar regulatory response in Sprague-Dawley rats. 21 This additional independent model corroborated our findings. We concluded that monocyte phagocytic system cells act as onsite controllers of interstitial sodium and blood pressure homeostasis, providing a local regulatory salt-sensitive TonEBP/ VEGF-C-mediated mechanism in the skin to maintain local electrolyte homeostasis and normal blood pressure in states of interstitial Na þ and Cl À accumulation. Failure of this physiological extrarenal regulatory mechanism leads to a salt-sensitive blood pressure response ( Figure 2 ).
SUPPORTIVE EVIDENCE FOR SODIUM STORAGE FROM HUMANS
We concomitantly worked on imaging Na þ in the skin and muscle. To this end, we adapted 23 Na-MRI. Combined with conventional 1 H-MRI, the technique can be coupled to estimate tissue water concomitantly. We developed a coil for 23 Na-MRI to measure sodium in the skin and the calf, immediately below the knee joint. 23 We calibrated our technique by making measurements in animals and the extremities of patients undergoing amputations and then made direct measurements of these tissues by means of ashing and atomic absorption spectrometry. When we were satisfied with reproducibility and precision, we made clinical human measurements. We found that Na þ in the skin and muscle was increased in patients with primary aldosteronism and that these concentrations decreased significantly and visually after aldosteronoma removal or spironolactone treatment ( Figure 3 ). We were interested to observe that these changes in Na þ storage occurred without concomitant changes in body weight. We conducted measurements in dialysis patients, before and after Na þ removal, and believe that the technique will have clinical utility. Our studies clearly indicate that Na þ storage in the skin and muscle can be readily visualized and the effect of dialysis on tissue Na þ removal can be quantified and monitored (unpublished observations).
We have made preliminary observations on patients with hyponatremia and hypernatremia. Conventional teaching has it that these disorders are primarily disturbances in osmoregulation and not Na þ regulation. We have inspected several patients and reported findings that suggest the situation may be a bit more complicated. 24 Detailed clinical studies of this issue using 23 Na-MRI and 1 H-MRI, as well as careful balance, will be necessary to pursue this issue further. We are working on such studies and recently reported a cohort of hypertensive patients and normotensive control subjects. 25 They ranged in age from 22 to 90 years. Suggesting that blood purification is sufficient for interstitial clearance of electrolytes and water, this research relies on investigation of renal electrolyte and water clearance mechanisms. (b) Extended research approach for body electrolyte balance and blood pressure homeostasis, based on the finding that interstitial electrolyte concentrations are higher than in blood ('skin Na þ storage'). Interstitial electrolyte balance is not achieved by renal blood purification alone, but relies on additional extrarenal regulatory mechanisms within the skin interstitium. Macrophages act as local osmosensors that regulate local interstitial electrolyte composition via a tonicity enhancer binding protein/ vascular endothelial growth factor-C (TonEBP/VEGF-C)-dependent mechanism, enhancing electrolyte clearance via VEGF-C/VEGFR3-mediated modulation of the lymph capillary network in the skin. eNOS, endothelial nitric oxide synthase; VEGFR, vascular endothelial growth factor receptor. Na-MRI image is above before and after removal of an aldosterone-producing tumor. Standards placed below the calf were 10, 20, 30, and 40 mmol/l sodium concentrations. Despite remarkable reduction in tissue Na
We observed age-dependent increases in Na þ content in the muscle in men, whereas the muscle Na þ content did not change with age in women. We estimated water content with conventional MRI and found no age-related increases in muscle water in men, despite remarkable Na þ accumulation, indicating water-free Na þ storage in muscle. With increasing age, there was Na þ deposition in the skin in both women and men; however, skin Na þ content remained lower in women. Similarly, this sex difference was found in skin water content, which was lower in women than in men. In contrast to muscle, increasing Na þ content was paralleled with increasing skin water content. The age-dependent increase in tissue Na þ content was associated with increasing blood pressure and the gender differences we observed in tissue Na þ content were associated with similar gender-dependent blood pressure profiles. Finally, when controlled for age, we found that patients with refractory hypertension had increased tissue Na þ content compared with normotensive controls. Suffice it to say, the 23 Na-MRI approach makes Na þ storage in the skin and muscle visible. Our findings suggest that these stores are dynamic. The conventional view that sodium is stored in the bone is correct, according to our ashing and atomic absorption spectrometric findings. However, bone stores do not appear to be particularly exchangeable, whereas Na þ deposited in the skin and muscle is more rapidly exchangeable. 7, 8 
LONG-TERM HUMAN SODIUM BALANCE
A simulated space flight to Mars, conducted in Moscow, Russia allowed us to inspect Na þ balance in the long term. 26 We performed two separate studies. The first study (Mars105) involved four normal men who were studied for 105 days. They received three fixed levels of sodium intake B200 (12), B150 (9) and B100 mmol per day (6 g salt per day). Numerous other investigations were concomitantly performed in these subjects and our study was not the primary aim of the simulated space flight. We did not randomize the order of the salt intakes, as psychologists assigned to the study maintained that a low-salt diet would not be palatable and recommended that the subjects be adapted 'more slowly'. The daily dietary Na þ content was selected on the basis of the INTERSALT measurements, 27 (a) Changes in systolic blood pressure (Syst. BP) aldosterone, cortisol, cortisone, and cortisol/cortisone excretion at varying levels of sodium intake. In the longer study, subjects were re-exposed to 12 g per day salt. (b) Effects on systolic blood pressure, body weight (BW), extracellular water (ECW), aldosterone excretion, and total-body sodium (TBNa) as subjects in the longer study were re-exposed to 12 g per day salt at 1, 2, 3, and 4 weeks. 24 h aldosterone excretion ¼ UAldoV; 24 h free cortisol excretion ¼ UFFV; 24 h free cortisone excretion ¼ UFEV; free cortisone to free cortisol ratio ¼ UFE/UFF. Adapted from Rakova et al. 26 estimated intakes for industrial societies as determined by experts, 28 and the recommendations for society at large by the Institute of Medicine. 29 We could not subject the volunteers to precisely the same meals (breakfast, lunch, dinner, snacks) day-in-day-out. Therefore, our nutritionist selected daily menus for each subject assuring some intake variability, but fixing all other dietary constituents as well, possibly so that only Na þ content was changed. 26 In Mars105, the subjects ate 12, 9, and 6 g per day salt every day with each period about 35 days. The other dietary constituents comprised the recommendations for humans. For instance, the potassium intake was 100 mmol per day, substantially higher than estimates for the United States. 30 Notable is the fact that we recovered in the urine 95% of the Na þ intake over each period of Na þ intake in Mars105. This finding corresponds to the observations of Heer et al., 4 who found that stool and sweat sodium losses under unstressed circumstances are trivial. 4 In the second Mars simulation (Mars520 205-day intervention), we were able to re-expose six normal men to the 12 g per day salt intake following the 6 per day salt intake. This state of affairs allowed us to re-examine the issue of Na þ loading. The recovery rates for each Na þ intake were as excellent as in Mars105. 26 Basically we asked four questions in this study. Does reduced Na þ intake lower blood pressure in normal men? Does Na þ storage occur? Is Na þ and water balance coupled? Are blood pressure and total-body Na þ related? Following conventional wisdom, all four questions would require a resounding 'yes' .
In the 205-day study, six subjects received for more than one month each , 12, 9, 6, and 12 g per day salt intake. Decreasing salt intake was associated with decreased blood pressure; the values increased when 12 g per day intake was resumed ( Figure 4a ). Daily urinary aldosterone excretion increased, and then decreased as expected. Urinary free cortisol excretion (UFFV) decreased with decreasing salt intake and then increased when salt intake was restored. Urinary free cortisone excretion (UFEV), the result of 11-b OHsteroid dehydrogenase-2 (11-b HSD-2) acting on cortisol, also decreased and then increased, whereas the ratio of the two increased with low salt intake and decreased with restoration of high-salt intake. This response suggested that 11-b HSD-2 activity decreased with high-salt intake. We next inspected the last week of the 6 g per day intake followed by the first week of the 12 g per day intake (Figure 4b) . By doubling salt intake, body weight increased, extracellular water increased, daily urinary aldosterone excretion (UAldoV) decreased, whereas DTBNa increased after 1 week. Blood pressure also increased, but that effect came substantially later. Had we terminated the study at that time, we would come to textbook conclusions. However, the 12 g per day salt intake was maintained. Over the next 4 weeks, blood pressure increased, body weight increased, but then decreased. Extracellular water decreased, UAldoV remained stable, whereas DTBNa decreased back to its original level despite constant high-salt intake. These results were unexpected.
When we reviewed daily UNaV, we were gratified at our 95% recoveries but puzzled at the large standard deviation in excretion. We therefore inspected UNaV separately for each subject. We detrended the data (set sodium intake constant) and observed astounding day-to-day variability in UNaV, UAldoV, UFFV, and UFEV that far exceeded variability in intake (Figure 5a) . A Fourier analysis (Figure 5b ) identified a 6-day peak for these variables. For UFFV and UFEV, a peak at about 28 days was also apparent. We next performed cross-correlation analysis to measure similarity between two waveforms as a function of a time lag applied to one of them. Briefly, there was no significant correlation between any excreted variable and Na þ intake on a day-to-day basis. However, a striking inverse cross-correlation was observed between UNaV and UAldoV, at Dt ¼ 0. This result indicates that the waveforms for UNaV and UAldoV coincided at the same periodicity (about 6 days) inversely. For UFFV and UFEV, the cross-correlations were direct rather than inverse. In the 105-day study shown above the subjects served a nightshift, which turned out to be a Zeitgeber (time setter) for this rhythm. However, inspecting the data from the 205-day study showed the same variable pattern with similar crosscorrelation results, although the circaseptan rhythm was less stable and varied between 6 and 9 days. The findings suggest that at constant salt intake, endogenous about-weekly rhythms in aldosterone and/or cortisol induce large and spontaneous rhythmical variability in urinary Na þ excretion, which is independent of salt intake.
We were particularly interested in DTBNa at fixed saltintake levels. In the 205-day study, we observed long-term infradian rhythms in DTBNa that were independent of salt intake (Figure 6a ). In the subject shown body weight increased as salt intake was decreased, whereas extracellular water remained constant and morning systolic blood pressure varied daily. Cross-correlation analysis revealed a direct correlation between DTBNa and UAldoV, although the peak lies about 1 week before Dt ¼ 0 (Figure 6b) . The cross-correlation with UFFV was inverse with the peak about 30 days before Dt ¼ 0, similar to UFEV. The ratio between the two values exhibited a direct relationship pretty much on Dt ¼ 0. We were interested to observe no relationship between DTBNa and blood pressure (Figure 6c ). Crosscorrelation analyses now including all subjects in the 205-day study gave results similar in kind to the single subject shown (Figure 6c ). The findings suggest that rhythms with period lengths in aldosterone and/or cortisol of months and longer induce rhythmic retention and release of body Na þ in humans, a process that is not related to dietary salt intake.
DISCUSSION
Returning to our questions, we conclude that when longterm constant salt intake is considered, salt intake and UNaV are not related on a day-to-day basis because of the inherent circaseptan rhythm in UNaV. However, on a long-term basis, indeed what goes in also comes out. Nonetheless, the implications of using single 24 h UNaV collections to separate sodium intakes, at least within this range, are obvious. The DTBNa and extracellular water may be related in the short term but evidently not in the long term, and DTBNa seems to have a mind of its own, independent of salt intake. Both the circaseptan rhythm we observed and the DTBNa rhythm are infradian, meaning that they are longer than 24 h circadian rhythms. However, the DTBNa infradian rhythm is far longer and more variable. We do not know the clocks controlling these rhythms, although we were interested in the fact that nightshift can serve as a Zeitgeber, a feature that house-staff physicians will surely appreciate.
We have said little about blood pressure. We only studied 10 subjects in the long-term balance study. We could not include a parallel control group at a totally constant salt intake to account for effects of 'environment', and so on.
We did not obtain 24 h ambulatory measurements. Blood pressure decreased with lowered salt intake in six subjects and was little changed in four others. We examined normotensive persons. We were interested to observe that blood pressure effects with lowered salt intake appeared to be delayed and required 42 weeks to reach a maximum reduction. In our recently reported cohort of refractory hypertensive patients and normotensive controls, we observed agedependent increases in the muscle and skin Na þ , although values were invariably lower in women compared with men. 25 These age-and sex-dependent differences in tissue Na þ content were paralleled by similar age-and gender-dependent increases in blood pressure in the same subjects. When controlled for age, we found that patients with refractory hypertension had increased tissue Na þ content compared with normotensive controls. These Fourier analyses seeking rhythmic patterns. Peaks at day 6 are apparent for sodium and aldosterone, whereas a 29-day peak appears for cortisol and cortisone. Power refers to power spectral density analysis of the rhythmical components. Adapted from Rakova et al. 26 UAldoV, urinary aldosterone excretion; UFEV, urinary free cortisone excretion; UFFV, urinary free cortisol excretion; UNaV, urinary sodium excretion.
findings suggest that tissue Na þ storage is either associated with, or is mechanistically related to, the development of essential hypertension in humans. Whether or not these observations should be translated into a dietary policy is a matter that we debate among ourselves. Experts recently weighed the evidence and concluded that reducing the currently high levels of salt consumption (about 9 g per day in this review) in the general population 'seems justifiable' , although in terms of safety, the lower limit of salt consumption has not been clearly identified. 31 The endorsement appears guarded and less than 'ringing' .
We believe that our long-term balance studies fit well with our notion of Na þ storage in skin and elsewhere and are also consistent with the idea that large amounts of Na þ can be stored without parallel water accumulation, as we found no relationship between body weight, extracellular water, and salt intake. We also suggest that our findings are consistent with far earlier studies, such as those of Dahl et al., 32 who used radioactive 22 
Na
þ to determine total exchangeable sodium. Dahl et al. restricted Na þ to 6 mmol per day (o250 mg) and found no correlation between changes in blood pressure and total exchangeable Na þ . They also observed variations in total exchangeable Na þ suggesting variations in DTBNa that they interpreted as storage in the bone. We would interpret their data somewhat differently. In any event, the variability and inconsistencies in their data can Figure 6 | Infradian rhythmicity of total body Na+ and its relationship to urinary hormones, body weight, extracellular water, and systolic blood pressure. (a) A long infradian rhythm for total-body sodium content (DTBNa) in a single subject. Body weight actually increases as sodium intake is reduced. Extracellular water (ECW) and systolic blood pressure (Syst. BP) are not affected by salt intake. (b) The crosscorrelations from this subject. (c) Cross-correlations between DTBNa and blood pressure (there was no significant relationship) and crosscorrelations from all subjects undergoing the 205-day protocol. The results were similar in kind for all subjects. Ordinate CCF is the crosscorrelation coefficient; abscissa Dt days. Adapted from Rakova et al. 26 UAldoV, urinary aldosterone excretion; UFEV, urinary free cortisone excretion; UFFV, urinary free cortisol excretion.
perhaps be explained by the data we generated in our longterm balance study and the observations by 23 Na-MRI. We suggest that our animal studies concerning skin Na þ storage, clearance of Na þ from the skin, and molecular regulatory events are interesting and shed some new avenues for research in the area of salt-sensitive hypertension. The development of 23 Na-MRI offers the perspective of performing human research to pursue the matter further. We have preliminary cross-sectional data in control subjects, hypertensive persons, and dialysis patients; however, longitudinal data and studies before and after interventions will be necessary to pursue this line of research further.
We are aware that our long-term balance study can render more information than we were able to include in our report on long-term balance. 26 We have not yet analyzed K þ and Cl À excretion and their interrelationships. Only Na þ as the Cl À salt influences blood pressure as others and we have observed earlier. 15 Cl À homeostasis would be expected to be particularly important to the hypertonic interstitium since alterations could influence other (unmeasured) anions perhaps influencing glycosaminoglycan charge density.
Finally, the question has been raised whether or not our findings abrogate the notion that the kidney is the final regulator of blood pressure through pressure natriuresis and related adjustments inherent in total-body autoregulation. Pressure natriuresis is commonly plotted as the relationship between blood pressure and 24 h UNaV. However, Guyton et al. 33, 34 taught about the kidney's 'infinite gain' and infinity is certainly longer than a day. Furthermore, the concept of autoregulation was directed as adjustments to flow, not pressure. Thus, dogmatic statements about pressure natriuresis in light of our findings are not warranted in our view. We believe that our findings would have interested Dr Guyton.
Whether or not our data speak to the public health issue about recommended salt intake is unclear. Within our group, we are divided in our viewpoints. Some experts maintain that dietary salt intake studies with cardiovascular end points are not feasible in free-living persons and cite an uncooperative posture on the part of the food industry. 35 Other authorities argue that the issue is obvious and no further studies are necessary. 36 However, we believe that good hypotheses should be rigorously tested. Our long-term balance study and our 23 Na-MRI evidence may provide insights into confounding variables that should be considered in such a study.
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